Laurence Zitvogel

151.4k total citations · 44 hit papers
492 papers, 79.1k citations indexed

About

Laurence Zitvogel is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Laurence Zitvogel has authored 492 papers receiving a total of 79.1k indexed citations (citations by other indexed papers that have themselves been cited), including 326 papers in Immunology, 235 papers in Oncology and 176 papers in Molecular Biology. Recurrent topics in Laurence Zitvogel's work include Immunotherapy and Immune Responses (226 papers), Cancer Immunotherapy and Biomarkers (160 papers) and Immune Cell Function and Interaction (157 papers). Laurence Zitvogel is often cited by papers focused on Immunotherapy and Immune Responses (226 papers), Cancer Immunotherapy and Biomarkers (160 papers) and Immune Cell Function and Interaction (157 papers). Laurence Zitvogel collaborates with scholars based in France, United States and Sweden. Laurence Zitvogel's co-authors include Guido Kroemer, Lorenzo Galluzzi, Oliver Kepp, Sebastián Amigorena, Clotilde Théry, François Ghiringhelli, Aitziber Buqué, Lionel Apétoh, Alexander Eggermont and Nathalie Chaput and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Laurence Zitvogel

484 papers receiving 78.1k citations

Hit Papers

Exosomes: composition, biogenesis and function 1995 2026 2005 2015 2002 2012 2006 2016 2011 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exosomes: composition, biogenesis and function
    2002 4.4k citations Laurence Zitvogel et al. profile →
  2. Immunogenic Cell Death in Cancer Therapy
    2012 2.6k citations Guido Kroemer, Lorenzo Galluzzi et al. profile →
  3. Calreticulin exposure dictates the immunogenicity of cancer cell death
    2006 2.5k citations François Ghiringhelli, Lionel Apétoh et al. Nature Medicine profile →
  4. Immunogenic cell death in cancer and infectious disease
    2016 2.2k citations Lorenzo Galluzzi, Oliver Kepp et al. profile →
  5. Innate or Adaptive Immunity? The Example of Natural Killer Cells
    2011 2.0k citations Éric Vivier, Laurence Zitvogel et al. profile →
  6. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
    1998 1.8k citations Laurence Zitvogel, Caroline Flament et al. Nature Medicine profile →
  7. The immune contexture in cancer prognosis and treatment
    2017 1.6k citations Wolf H. Fridman, Laurence Zitvogel et al. Nature Reviews Clinical Oncology profile →
  8. Antigen Presentation and T Cell Stimulation by Dendritic Cells
    2002 1.4k citations Laurence Zitvogel et al. profile →
  9. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
    2001 1.3k citations Caroline Flament, Eric Angevin et al. Nature Medicine profile →
  10. Immunological aspects of cancer chemotherapy
    2007 1.3k citations Laurence Zitvogel, Lionel Apétoh et al. profile →
  11. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
    2005 1.2k citations François Ghiringhelli, Nathalie Chaput et al. profile →
  12. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
    2015 1.1k citations Lorenzo Galluzzi, Oliver Kepp et al. profile →
  13. Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
    2011 1.1k citations Mickaël Michaud, Isabelle Martins et al. profile →
  14. Cancer despite immunosurveillance: immunoselection and immunosubversion
    2006 986 citations Laurence Zitvogel, Guido Kroemer et al. profile →
  15. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
    2016 976 citations Jonathan M. Pitt, Aurélien Marabelle et al. Annals of Oncology profile →
  16. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
    2006 968 citations François Ghiringhelli, Sylvain Ladoire et al. profile →
  17. Type I interferons in anticancer immunity
    2015 964 citations Laurence Zitvogel, Lorenzo Galluzzi et al. profile →
  18. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
    2020 932 citations Lorenzo Galluzzi, Laurence Zitvogel et al. Nature Reviews Clinical Oncology profile →
  19. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
    1995 928 citations Laurence Zitvogel et al. Nature Medicine profile →
  20. Immunogenic cell stress and death
    2022 919 citations Guido Kroemer, Laurence Zitvogel et al. profile →
  21. Immunogenic death of colon cancer cells treated with oxaliplatin
    2009 917 citations Oliver Kepp, Isabelle Martins et al. profile →
  22. Immunogenic and tolerogenic cell death
    2009 916 citations Laurence Zitvogel, Guido Kroemer et al. profile →
  23. Molecular Characterization of Dendritic Cell-Derived Exosomes
    1999 906 citations Laurence Zitvogel et al. profile →
  24. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
    1999 857 citations Caroline Flament, Laurence Zitvogel et al. Nature Medicine profile →
  25. Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
    2013 856 citations Laurence Zitvogel et al. profile →
  26. The microbiome and human cancer
    2021 834 citations Laurence Zitvogel, Jennifer A. Wargo et al. profile →
  27. Malignant effusions and immunogenic tumour-derived exosomes
    2002 793 citations Fabrice André, Caroline Flament et al. profile →
  28. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
    2016 790 citations Jonathan M. Pitt, Marie Vétizou et al. profile →
  29. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    1996 717 citations Laurence Zitvogel et al. profile →
  30. Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
    2009 688 citations Oliver Kepp, Laurence Zitvogel et al. profile →
  31. Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
    2013 681 citations Laurence Zitvogel, Lorenzo Galluzzi et al. profile →
  32. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
    2018 631 citations Lisa Derosa, Marine Fidelle et al. Annals of Oncology profile →
  33. Cell death modalities: classification and pathophysiological implications
    2007 615 citations Lorenzo Galluzzi, Ilio Vitale et al. profile →
  34. Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation
    2005 588 citations François Ghiringhelli, Guido Kroemer et al. profile →
  35. The secret ally: immunostimulation by anticancer drugs
    2012 545 citations Lorenzo Galluzzi, Laura Senovilla et al. profile →
  36. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
    2018 528 citations Laurence Zitvogel, Yuting Ma et al. profile →
  37. Immune parameters affecting the efficacy of chemotherapeutic regimens
    2011 518 citations Laurence Zitvogel, Oliver Kepp et al. Nature Reviews Clinical Oncology profile →
  38. Dendritic cell–derived exosomes for cancer therapy
    2016 507 citations Jonathan M. Pitt, Fabrice André et al. profile →
  39. Molecular mechanisms of ATP secretion during immunogenic cell death
    2013 437 citations Yuting Ma, Abdul Qader Sukkurwala et al. profile →
  40. Extracellular vesicles: masters of intercellular communication and potential clinical interventions
    2016 402 citations Jonathan M. Pitt, Guido Kroemer et al. profile →
  41. Anticancer effects of the microbiome and its products
    2017 385 citations Laurence Zitvogel, Romain Daillère et al. profile →
  42. The gut microbiota influences anticancer immunosurveillance and general health
    2018 366 citations Romain Daillère, Laurence Zitvogel et al. Nature Reviews Clinical Oncology profile →
  43. Microbiome and Anticancer Immunosurveillance
    2016 359 citations Laurence Zitvogel, Maha Ayyoub et al. profile →
  44. Targeting the gut and tumor microbiota in cancer
    2022 329 citations Guido Kroemer, Laurence Zitvogel et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Zitvogel France 123 42.4k 31.7k 31.3k 10.1k 7.4k 492 79.1k
Drew M. Pardoll United States 132 46.7k 1.1× 23.5k 0.7× 45.0k 1.4× 6.7k 0.7× 3.7k 0.5× 403 83.2k
Mark J. Smyth Australia 143 52.9k 1.2× 20.2k 0.6× 37.6k 1.2× 6.5k 0.7× 3.3k 0.4× 595 81.6k
Lorenzo Galluzzi France 123 21.1k 0.5× 31.6k 1.0× 20.1k 0.6× 8.2k 0.8× 6.0k 0.8× 444 67.3k
Lisa M. Coussens United States 81 21.6k 0.5× 23.6k 0.7× 27.4k 0.9× 12.5k 1.2× 4.6k 0.6× 198 61.3k
Jeffrey W. Pollard United States 100 30.0k 0.7× 20.4k 0.6× 19.8k 0.6× 8.0k 0.8× 4.0k 0.5× 252 55.0k
Jedd D. Wolchok United States 119 29.7k 0.7× 16.2k 0.5× 45.3k 1.4× 4.6k 0.5× 3.7k 0.5× 568 65.0k
Lloyd J. Old United States 135 47.4k 1.1× 33.2k 1.0× 33.7k 1.1× 7.3k 0.7× 2.2k 0.3× 722 85.7k
Tak W. Mak Canada 156 34.0k 0.8× 49.6k 1.6× 22.6k 0.7× 17.0k 1.7× 1.9k 0.3× 710 96.1k
Robert D. Schreiber United States 119 48.3k 1.1× 20.7k 0.7× 33.6k 1.1× 7.5k 0.7× 1.7k 0.2× 385 79.6k
Dmitry I. Gabrilovich United States 97 41.6k 1.0× 15.6k 0.5× 25.8k 0.8× 5.9k 0.6× 3.1k 0.4× 266 57.3k

Countries citing papers authored by Laurence Zitvogel

Since Specialization
Citations

This map shows the geographic impact of Laurence Zitvogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Zitvogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Zitvogel more than expected).

Fields of papers citing papers by Laurence Zitvogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Zitvogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Zitvogel. The network helps show where Laurence Zitvogel may publish in the future.

Co-authorship network of co-authors of Laurence Zitvogel

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Zitvogel. A scholar is included among the top collaborators of Laurence Zitvogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Zitvogel. Laurence Zitvogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Andrew Maltez, Marine Fidelle, Bertrand Routy, et al.. (2023). Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. Nature Reviews Clinical Oncology. 20(9). 583–603. 78 indexed citations
2.
Derosa, Lisa, Bertrand Routy, Antoine Desîlets, et al.. (2021). Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?. Cancer Discovery. 11(10). 2396–2412. 100 indexed citations
3.
Fridman, Wolf H., Laurence Zitvogel, Catherine Sautès‐Fridman, & Guido Kroemer. (2017). The immune contexture in cancer prognosis and treatment. Nature Reviews Clinical Oncology. 14(12). 717–734. 1555 indexed citations breakdown →
4.
Young, Arabella, Shin Foong Ngiow, Ann‐Marie Patch, et al.. (2017). A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. Cancer Research. 78(4). 1003–1016. 296 indexed citations
5.
Fend, Laetitia, Takahiro Yamazaki, Murielle Gantzer, et al.. (2017). Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. Cancer Research. 77(15). 4146–4157. 108 indexed citations
6.
Pitt, Jonathan M., Aurélien Marabelle, Alexander Eggermont, et al.. (2016). Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Annals of Oncology. 27(8). 1482–1492. 976 indexed citations breakdown →
7.
Vacchelli, Erika, Yuting Ma, Elisa Elena Baracco, Laurence Zitvogel, & Guido Kroemer. (2016). Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1. OncoImmunology. 5(5). e1118600–e1118600. 15 indexed citations
8.
Jacquelot, Nicolas, David Enot, Sylvie Rusakiewicz, et al.. (2016). Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis. Journal of Investigative Dermatology. 136(5). 994–1001. 22 indexed citations
9.
Kroemer, Guido, Laura Senovilla, Lorenzo Galluzzi, Fabrice André, & Laurence Zitvogel. (2015). Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine. 21(10). 1128–1138. 229 indexed citations
10.
Bloy, Norma, Jonathan Pol, Fernando Aranda, et al.. (2014). Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology. 3(11). e963424–e963424. 64 indexed citations
11.
Aranda, Fernando, Erika Vacchelli, Jérôme Galon, et al.. (2014). Trial Watch. OncoImmunology. 3(2). e27297–e27297. 93 indexed citations
12.
Ladoire, Sylvain, Dalil Hannani, Marie Vétizou, et al.. (2013). Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity. Antioxidants and Redox Signaling. 20(7). 1098–1116. 37 indexed citations
13.
Goèré, Diane, Caroline Flament, Sylvie Rusakiewicz, et al.. (2013). Potent Immunomodulatory Effects of the Trifunctional Antibody Catumaxomab. Cancer Research. 73(15). 4663–4673. 34 indexed citations
14.
Senovilla, Laura, Ilio Vitale, Isabelle Martins, et al.. (2012). An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells. OncoImmunology. 2(1). e22409–e22409. 23 indexed citations
15.
Martins, Isabelle, Mickaël Michaud, Abdul Qader Sukkurwala, et al.. (2012). Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy. 8(3). 413–415. 90 indexed citations
16.
Zitvogel, Laurence & Guido Kroemer. (2012). Targeting PD-1/PD-L1 interactions for cancer immunotherapy. OncoImmunology. 1(8). 1223–1225. 307 indexed citations
17.
Salaun, Bruno, Laurence Zitvogel, Carine Asselin‐Paturel, et al.. (2011). TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer. Cancer Research. 71(5). 1607–1614. 93 indexed citations
18.
Mattarollo, Stephen R., Sherene Loi, Helene Duret, et al.. (2011). Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors. Cancer Research. 71(14). 4809–4820. 256 indexed citations
19.
Zitvogel, Laurence, Oliver Kepp, Laetitia Aymeric, et al.. (2010). Integration of Host-Related Signatures with Cancer Cell–Derived Predictors for the Optimal Management of Anticancer Chemotherapy. Cancer Research. 70(23). 9538–9543. 23 indexed citations
20.
Borg, Christophe, Julien Taı̈eb, Magali Terme, et al.. (2003). Immunothérapie fondée sur les cellules natural killer : implication des cellules dendritiques. Bulletin du Cancer. 90(8). 699–705. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Drew M. Pardoll Breakdown of academic impact, for papers by Mark J. Smyth Breakdown of academic impact, for papers by Lorenzo Galluzzi Breakdown of academic impact, for papers by Lisa M. Coussens Breakdown of academic impact, for papers by Jeffrey W. Pollard Breakdown of academic impact, for papers by Jedd D. Wolchok Breakdown of academic impact, for papers by Lloyd J. Old Breakdown of academic impact, for papers by Tak W. Mak Breakdown of academic impact, for papers by Robert D. Schreiber Breakdown of academic impact, for papers by Dmitry I. Gabrilovich
Rankless by CCL
2026